Resources

Coulter Partners successfully led a search for Salvia BioElectronics B.V. to place Jill Schiaparelli as Chair of its Board of Directors.

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

Chris Molloy on scale-up policy, improving treatments pipeline, LSSP, GMM regulation, LLSW, MDUK's Pedal Paddle Peak and Dr Sally Ann Forsyth OBE

Key takeaways as another BIA Summer Party 2026 delivers for the life sciences sector

The Global Talent visa route has been made easier for research-intensive businesses to attract international researchers and specialists

Myricx Bio reached agreement to be acquired by Novartis for up to $1.5 billion.

Astex has entered into an exclusive, worldwide research collaboration and license agreement with Genentech.

Brandon Capital announced the successful exit of its portfolio company Myricx Bio.

Craig Marshall, $1.5B OrganOx exit CEO, joins Oxford Medical Products board

The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.

Innovation Orbit 2026 is FI Group by EPSA’s international guide to grants, R&D tax credits and public incentives for businesses planning R&D, CAPEX, digital transformation or decarbonisation projects.

We must engage with the Chinese ecosystem – this is how

KQ Labs, a leading accelerator that has helped early-stage life sciences innovators raise over £230 million, is now accepting applications for its ninth programme

Global drug development consultancy, Boyds has achieved a Bronze Medal from EcoVadis, a global leader in business sustainability assessments.

MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery

BIO Convention, RQ Bio’s oversubscribed Series A, BIA Summer Party, expanding overseas webinar and BIA BD vacancy

Columbus has published a new whitepaper, Digital Compliance for MedTech: Managing Regulatory Complexity.